Amatuximab Completed Phase 2 Trials for Malignant Pleural Mesothelioma (MPM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00738582An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma